Home » Newsletters » BioWorld Science

BioWorld Science

Aug. 12, 2010

View Archived Issues

Basilea Pharmaceutica claims new antibacterial agents

Avexa and Shanghai TargetDrug describe new NS5B inhibitors

Orchid Chemicals & Pharmaceuticals discovers new PDE4 inhibitors

Hybrigenics presents new USP7 inhibitors

German scientists disclose new antiarrhythmic agents

Algeta begins phase I/IIa trial of Alpharadin/docetaxel combination in CRPC

Herceptin approved in Canada for HER2-positive stomach cancer

Epitherix identifies novel chemical scaffolds targeting Wnt pathway

Karo Bio to present phase III development plan for eprotirome in high-risk HeFH

Carbamazepine enhances autophagy and decreases hepatic fibrosis in vivo

Serum uric acid level is a biomarker for new-onset diabetes

Scientists select new H3 receptor antagonists as clinical candidates for sleep disorders

Scientists identify potential susceptibility loci for endometriosis

Midbrain [18F]-fallypride PET can reveal impulsivity in individuals

Dr. Reddy's launches biosimilar darbepoetin alfa for anemia in India

Crucell, IAVI and BIDMC to conduct phase I AdVac-based AIDS vaccine trial

D-Pharm reports results from DP-b99 cardiac safety study

FDA approves NovoSeven RT 8-mg vial for hemophilia A and B

FDA clears Curemark's IND for CM-4612 in ADHD

Healthpoint advances Collagenase Santyl for diabetes-associated foot ulcers

Pathway Therapeutics raises funds for PI3K inhibitor development

Trigemina reports phase IIa data on TI-001 in chronic daily headache

ACT and Brown Cancer Center collaborate to identify cancer therapeutics

Biotest reports final data from phase IIa trial of BT-061 in RA

Biotest updates development program for BT-062 in multiple myeloma

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 12, 2026.
Cas and effect: Merck’s phase III ripples HIF-2α space
BioWorld
Oddsmakers wasted no time figuring the market chances after Merck & Co. Inc. rolled out data from the phase III Litespark-011 study testing its oral...
Brain’s hidden tau-clearing pathway uncovered
BioWorld Science
Researchers at INSERM and collaborators have identified hypothalamic tanycytes as mediators of tau clearance and shown that their structural and genetic...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 10, 2026
MSD synthesizes α-synuclein PET agents
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has prepared and tested new positron emission tomography (PET) agents for binding and imaging α-synuclein (SNCA) for the diagnosis...